María Soengas
#44,199
Most Influential Person Now
Spanish immunologist and academic
María Soengas's AcademicInfluence.com Rankings
María Soengasbiology Degrees
Biology
#1955
World Rank
#3153
Historical Rank
Immunology
#1071
World Rank
#1097
Historical Rank
Download Badge
Biology
María Soengas's Degrees
- PhD Immunology University of Barcelona
- Doctorate Medicine University of Barcelona
Why Is María Soengas Influential?
(Suggest an Edit or Addition)According to Wikipedia, María S. Soengas is a Spanish immunologist who is a senior scientist at the Spanish National Cancer Research Center . Her research considers melanoma and the development of new therapeutic strategies. She was elected to the European Molecular Biology Organization in 2022.
María Soengas's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- BRAFE600-associated senescence-like cell cycle arrest of human naevi (2005) (2109)
- Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo (1998) (1385)
- Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (2001) (990)
- Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. (2006) (964)
- Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. (1998) (903)
- Apoptosis and melanoma chemoresistance (2003) (814)
- Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. (1999) (712)
- Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway (2006) (348)
- BRAF and NRAS mutations in melanoma and melanocytic nevi (2006) (245)
- Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. (2005) (239)
- An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. (2007) (218)
- C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells (2008) (193)
- Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition (2007) (189)
- Artificial skin in perspective: concepts and applications (2011) (179)
- Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. (2009) (169)
- c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle (2008) (146)
- A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. (2006) (135)
- Melanoma proliferation and chemoresistance controlled by the DEK oncogene. (2009) (132)
- UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis. (2016) (119)
- Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-resistant Squamous Cell Carcinoma Cells by Induction of Noxa* (2006) (118)
- Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine (2017) (108)
- Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. (2007) (106)
- ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. (2009) (103)
- RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. (2014) (88)
- Site‐directed mutagenesis at the Exo III motif of phi 29 DNA polymerase; overlapping structural domains for the 3′‐5′ exonuclease and strand‐displacement activities. (1992) (80)
- The state of melanoma: challenges and opportunities (2016) (79)
- Helix-destabilizing activity of phi 29 single-stranded DNA binding protein: effect on the elongation rate during strand displacement DNA replication. (1995) (78)
- Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins (2007) (77)
- Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma. (2009) (75)
- Control of Tumorigenesis and Chemoresistance by the DEK Oncogene (2010) (74)
- Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation (2003) (71)
- Chemical Blockage of the Proteasome Inhibitory Function of Bortezomib (2006) (52)
- 3'-->5' exonuclease active site of phi 29 DNA polymerase. Evidence favoring a metal ion-assisted reaction mechanism. (1994) (51)
- Melanoma models for the next generation of therapies. (2021) (49)
- Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells (2007) (46)
- p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors. (2019) (43)
- Protein kinase C inhibitor and irradiation-induced apoptosis: relevance of the cytochrome c-mediated caspase-9 death pathway. (2000) (40)
- PP2A-B56α Controls Oncogene-Induced Senescence in Normal and Tumor Human Melanocytic Cells (2011) (40)
- KLF9-dependent ROS regulate melanoma progression in stage-specific manner (2019) (37)
- Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers (2016) (35)
- Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5 (2016) (34)
- E2F1-Dependent Oncogenic Addiction of Melanoma Cells to MDM2 (2011) (34)
- Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state (2020) (34)
- Complex formation between phage phi 29 single-stranded DNA binding protein and DNA. (1994) (32)
- Protein-nucleic acid interactions in bacteriophage phi 29 DNA replication. (1995) (28)
- UNR / CSDE 1 drives a post-transcriptional program to promote melanoma invasion and metastasis (2016) (25)
- Apaf-1 expression in malignant melanoma (2006) (23)
- Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies (2016) (23)
- DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer (2014) (23)
- Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol (2008) (22)
- ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma. (2017) (22)
- The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy (2011) (21)
- RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development (2015) (21)
- Self-killing of melanoma cells by cytosolic delivery of dsRNA: Wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cells (2010) (21)
- Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy. (2016) (20)
- Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1 (2017) (19)
- The State of Melanoma: Emergent Challenges and Opportunities (2021) (18)
- p53 and p73: seeing double? (2000) (15)
- Comment on "Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo". (2008) (15)
- Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: implications for melanoma progression and drug resistance (2012) (15)
- The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis (2016) (14)
- The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer (2018) (13)
- TYRP1 mRNA goes fishing for miRNAs in melanoma (2017) (11)
- Structural Features of φ29 Single-stranded DNA-binding Protein (1997) (11)
- Physiological models for in vivo imaging and targeting the lymphatic system: nanoparticles and extracellular vesicles. (2021) (10)
- Hyperactivated endolysosomal trafficking in melanoma (2015) (9)
- Melatonin inhibits human melanoma cells proliferation and invasion via cell cycle arrest and cytoskeleton remodeling (2020) (8)
- Location, Location, Location: Spatio-Temporal Cues That Define the Cell of Origin in Melanoma. (2017) (8)
- Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis (2021) (7)
- Structural features of phi29 single-stranded DNA-binding protein. I. Environment of tyrosines in terms of complex formation with DNA. (1997) (6)
- Cancer: Ins and outs of tumour control (2008) (5)
- UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis. (2019) (4)
- Lymph: (Fe)rrying Melanoma to Safety. (2020) (4)
- Antimetastatic dsRNA mimics identified by live imaging of pathogenic neolymphangiogenesis (2019) (3)
- The p 53 and p 73 : seeing double ? (3)
- T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis (2023) (3)
- Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics (2021) (2)
- Pre-clinical evaluation of bortezomib, doxorubicin, dexamethasone, and lenalidomide in multiple myeloma (MM) (2008) (2)
- TRANSAUTOPHAGY: European network for multidisciplinary research and translation of autophagy knowledge (2016) (2)
- A novel BH3 mimetic reveals a MAPK-dependent mechanism of melanoma cell survival controlled by p53 and reactive oxygen species (2006) (1)
- Comment on: Absence of Senescence-Associated β-Galactosidase Activity in Human Melanocytic Nevi In Vivo. Authors' reply (2008) (1)
- Cell position matters in tumour development (2022) (0)
- New role of the endoplasmic reticulum in the control of melanocyte transformation (2006) (0)
- Physics: Salt mined (2009) (0)
- p53 action in apoptosis and senescence (2000) (0)
- 939. Adenovirus-Mediated TA-p73β Gene Transfer Leads to Chemosensitization of Human Malignant Melanoma (2006) (0)
- Structural Features of φ29 Single-stranded DNA-binding Protein (1997) (0)
- DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer (2014) (0)
- Let's make it happen: for gender equality in science! (2015) (0)
- BO-110, a dsRNA-Based Anticancer Agent (2014) (0)
- Ze'ev Ronai (2013) (0)
- Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1 (2017) (0)
- The residues forming the 3 ‘ + 5 ’ exonuclease active site of 429 DNA polymerase , located at the N-terminal conserved motifs (2001) (0)
- endolysosomal pathways in melanoma maintenance and drug response : il36 (2011) (0)
- Systemic effects of melanoma-secreted MIDKINE in the inhibition of dendritic cell differentiation and function (2022) (0)
- Structural features of phi29 single-stranded DNA-binding protein. II. Global conformation of phi29 single-stranded DNA-binding protein and the effects of complex formation on the protein and the single-stranded DNA. (1997) (0)
- Protein Kinase C Inhibitor and Irradiation-induced Apoptosis : Relevance of the Cytochrome c-mediated Caspase-9 Death Pathway 1 (2000) (0)
- Looping tumor suppression (2008) (0)
- The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer (2018) (0)
- Activation of p53 Signaling Is Synergistically Enhanced by Bcl-2 Inhibition through Induction of Noxa and Bak/Bax Heterodimers Resulting in Apoptosis of AML Stem Cells (2008) (0)
- Tumor immunity and immunosurveillance (PP-093) (2010) (0)
- Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state (2020) (0)
- ' s response to reviews Title : DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer (2014) (0)
This paper list is powered by the following services:
Other Resources About María Soengas
What Schools Are Affiliated With María Soengas?
María Soengas is affiliated with the following schools:
